http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08291061-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa6e4421d9e1159b6012d9bf702be572 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1995-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a12cc39bd65a11f48b7f740f6dc31e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf5bcb728a080808b3a00a2993af2fc |
| publicationDate | 1996-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08291061-A |
| titleOfInvention | Method of combined administration of anticancer agents and anticancer agents that can be used in combination |
| abstract | (57) [Summary] [Object] To enhance the effect of a conventional anticancer agent comprising a platinum complex, a combination of the platinum complex and a known anticancer agent is provided. [Structure] A known anticancer agent such as cisplatin or vincristine and an anticancer agent comprising a platinum complex of (Chemical Formula 1) are co-administered. As a result, the platinum complex (Chemical Formula 1), which did not function as an anticancer agent unless used in a large amount, can function as an anticancer agent even in a small amount. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010527908-A |
| priorityDate | 1995-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.